# IP (International Paper Co.) Stock Analysis — 2026-10-14

> International Paper at $31.81 sits 36.7% below its 52-week high and just 8.7% above its low, pricing in a fundamental deterioration that Wall Street's $44-$61 targets largely ignore. H1 2026 adjusted EPS collapsed to $0.19 ($0.15 in Q1, $0.04 in Q2, down 77.8% y/y in Q2), revenue missed in both quar...

- Verdict: **Sell**
- Price at analysis: $31.81
- 1Y price target: $27.00 (-15.1% implied)
- 3Y price target: $29.00 (-8.8% implied)
- Technicals: RSI 31, MACD bearish
- Source: https://stockquantai.com/research/ip/2026-10-14

## Executive Summary

International Paper at $31.81 sits 36.7% below its 52-week high and just 8.7% above its low, pricing in a fundamental deterioration that Wall Street's $44-$61 targets largely ignore. H1 2026 adjusted EPS collapsed to $0.19 ($0.15 in Q1, $0.04 in Q2, down 77.8% y/y in Q2), revenue missed in both quarters (Q2 $6.00B -2.2% y/y vs $6.17B consensus), and management lowered 2026 adjusted EBITDA guidance on higher costs and heavy maintenance outages. The 8.4% post-Q1 plunge to a near 3-year low was earned, not overdone.

The bull case rests on a future linerboard pricing cycle, 80/20 transformation with 51 facilities closed, DS Smith ($7.2B) scale in Europe, and a 5.8% dividend yield. We are skeptical: the payout ($1.85 annualized vs $0.19 H1 earnings) is debt-funded at the trough, DS Smith adds leverage and European restructuring risk, and announced price hikes have not yet flowed through while box demand is only modestly positive (+1.7% NA in Q2). With Citi flagging a tough packaging setup and cutting to $44, and earnings momentum still negative, cheap on sales (~0.70x) can get cheaper on earnings. We see further downside over 12 months before any transformation payoff.

## Price Targets

| Horizon | Price | Implied Growth |
|---|---|---|
| 1 Year | $27.00 | -15.1% |
| 3 Year | $29.00 | -8.8% |

## Scenarios

| Scenario | 1Y Price | 3Y Price | Thesis |
|---|---|---|---|
| Hyper Bull | $55.00 | $68.00 | Linerboard hikes stick, box volumes accelerate to mid-single digits, DS Smith synergies exceed $500M, and spin-off unlocks value. EBITDA surges, dividend secured, multiple re-rates to mid-cycle 8-9x. Stock reclaims $55 prior top. |
| Bull | $42.00 | $52.00 | Pricing realization in H2 2026 plus cost savings drive 2027 earnings recovery toward $2.50-3.00. Market rewards scale and 5%+ yield, closing gap to Citi $44 and partway to JPM $61. Transformation credibility restored. |
| Neutral | $32.00 | $38.00 | Trough earnings stabilize around $1.00-1.50 as price hikes offset costs with 1-2% volume growth. Dividend maintained but no growth; stock trades sideways 0.7-0.8x sales awaiting proof of DS Smith synergies and spin-off. |
| Bear | $27.00 | $29.00 | Price increases stall, maintenance and integration costs persist, and 2026-2027 estimates cut again. Payout ratio forces dividend reassessment, leverage stays high, and cyclical derating to 6x depressed EBITDA drives new 3-year lows. |
| Hyper Bear | $20.00 | $18.00 | Recession hits box demand, European losses widen, DS Smith goodwill impaired, and dividend cut 40-50%. Highly cyclical balance sheet stress with persistent sub-5% EBITDA margins leads to structural value destruction. |

## Key Metrics

- Market Cap: $16.81B
- P/E Ratio: N/A (depressed - H1 2026 adj EPS $0.19)
- P/S Ratio: 0.70x (on ~$24B annualized sales)
- Revenue: $6.00B Q2 2026 (-2.2% y/y)
- Net Income: Near breakeven (Q2 GAAP -$0.02/share)
- EPS: $0.04 Q2 2026 adj (-77.8% y/y); $0.15 Q1
- Dividend Yield: 5.82% ($1.85 annualized)
- Beta: N/A
- 52-Week High: $50.25
- 52-Week Low: $29.26
- Short Interest: N/A

## Micro Analysis

Company-specific execution is lagging promises: sales misses, margin collapse, guidance cuts, and an uncovered dividend offset cost actions and M&A scale.

- **Earnings collapse and guidance cut**: Q1 2026 adj EPS $0.15 missed $0.18 consensus, down from $0.17 y/y; Q2 adj EPS $0.04 down 77.8% y/y (beat -$0.04 consensus only because bar was negative) with GAAP loss of -$0.02. Management lowered 2026 adjusted EBITDA outlook on higher costs. Elevated planned maintenance outages pressured Q2 profitability.
- **Revenue misses despite scale**: Q2 net sales $6.00B declined 2.2% y/y and missed $6.17B consensus by 2.7%; Q1 also narrowly missed. North American box volumes rose only 1.7% in Q2, insufficient to offset pricing/cost/mix and European softness. Annualized ~$24B revenue implies ~0.70x P/S, cheap because profitability is near zero.
- **80/20 transformation unproven**: Closed or announced closure of 51 facilities, aggressive cost reductions, asset modernization, and $360M North Pacific Paper (NORPAC) acquisition for West Coast flexibility. Yet margins underwhelmed in quarterly report (-8% reaction) and savings are being absorbed by maintenance, integration, and inflation. Jefferies conference highlighted productivity gains but also macro volatility.
- **DS Smith leverage and Europe overhang**: $7.2B DS Smith deal makes IP ~1/3 of NA corrugated plus large European footprint, but adds debt, restructuring charges, and exposure to weaker European demand. Planned European restructuring and spin-off add execution risk and limit near-term deleveraging capacity.
- **Dividend sustainability risk**: Quarterly $0.4625 common dividend ($1.85 annualized) = 5.8% yield at $31.81, plus $1.00 preferred. H1 2026 adj earnings $0.19 vs $0.925 dividends paid = >480% payout ratio. Management signals confidence, but on trough earnings the dividend is funded by balance sheet/cash flow, raising cut risk if EBITDA recovery slips into 2027.

## Macro Analysis

Packaging cycle is bottoming but not yet turning; input cost, maintenance, and European weakness dominate while linerboard price hikes offer only future optionality.

- **Linerboard pricing cycle inflecting slowly**: JPMorgan upgraded to Overweight July 2026 with $61 target on improving U.S. linerboard pricing and tightening supply-demand. IP announced price increases and improved productivity. However realization lags 1-2 quarters and Q1/Q2 results show no margin benefit yet; Citi in April still flagged tough sector setup and cut to $44.
- **Cyclical industrial demand soft**: End markets in industrial, consumer products, and manufacturing remain choppy. Modest 1.7% NA box growth in Q2 is positive but well below a robust recovery. Global packaging to $1.75T by 2035 on sustainability is a long-term tailwind, not a 2026 earnings driver.
- **Cost inflation and maintenance cycle**: High planned maintenance outages crushed Q2, and Q1/Q2 commentary cited higher costs driving downbeat Q2 guidance and lower 2026 EBITDA view. Fiber, freight, energy, and labor remain sticky, delaying operating leverage from plant closures.
- **Europe drag**: Expanded European presence via DS Smith increases exposure to slower growth, energy costs, and restructuring. Planned spin-off may unlock value in 2-3 years but creates near-term dis-synergies and management distraction.
- **Sentiment washed out but not capitulated**: Stock -36.7% from $50.25 high, RSI 30.9 oversold, 4 consecutive down days, near 3-year low after Q1. Value screens flag high yield and JPM $61 implies 92% upside, but Wolf Report seller since early 2025 ($55-56 top) and Citi cut show smart money de-risking cyclicals into estimate cuts.

## Revenue Opportunities

- **Linerboard price realization** (potential: high): Announced U.S. linerboard and box price increases, if sustained through H2 2026-2027 with tightening supply after 51 closures, could add hundreds of millions to EBITDA given ~1/3 NA share. JPM thesis hinges on this.
- **DS Smith synergies and European scale** (potential: medium): Procurement, mill optimization, and rigid-paper / corrugated cross-sell in Europe plus eventual spin-off could unlock sum-of-parts value and improve through-cycle margins.
- **NORPAC and West Coast optimization** (potential: medium): $360M North Pacific Paper acquisition improves West Coast presence, operational flexibility, and lower delivered costs; lightweight high-strength containerboard grades lower shipping costs and align with sustainability demand.

## Headwinds

- **Margin and estimate downgrade momentum** (severity: high): Back-to-back revenue misses, 77.8% EPS decline, and lowered 2026 EBITDA outlook show forecasts still falling. 8% post-earnings drop signals loss of credibility; further cuts would pressure multiple and dividend.
- **Integration and restructuring execution** (severity: high): $7.2B DS Smith integration, 51 plant closures, European restructuring, and planned spin-off create stranded costs, customer disruption, and capex/maintenance headwinds. Benefits pushed to 2027+.
- **Uncovered dividend and leverage** (severity: medium): 5.8% yield requires ~$980M annual common payout vs near-zero earnings and $6B quarterly sales declining. Debt from DS Smith + NORPAC limits buybacks/capex flexibility; a cut would trigger income-investor exodus.

## Tailwinds

- **Oversold technical and value screen** (strength: medium): RSI 30.9, 36.7% below high, near $29.26 low. Deep value and 5%+ yield attract contrarians; any Q3 beat or price-hike traction could spark sharp relief rally.
- **Cost takeout from 80/20** (strength: medium): Facility closures, asset modernization, and 80/20 customer pruning should structurally lower fixed costs and improve mix toward higher-margin strategic accounts over 2-3 years.
- **Sustainability-driven packaging growth** (strength: low): Shift from plastic to fiber, e-commerce, and lightweight corrugated supports long-term volume; IP as global leader with Forestland Stewards conservation credentials is well positioned for 2026-2035 growth to $1.75T market.

## Disclaimer

This report was generated by an AI model and is for informational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities. Always conduct your own research and consult a licensed financial advisor before making investment decisions.